Focused Alpha’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Focused Alpha's CORT Position: Q2 2026 in Review
Focused Alpha sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 32,421 shares — an estimated $1.31M sold.
Focused Alpha first reported a position in CORT in Q1 2026 and held it in 1 quarter. The position peaked at $1.31M in Q1 2026. 425 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Focused Alpha reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
- Focused Alpha sold 32,421 Corcept Therapeutics shares in Q2 2026, an estimated $1.31M.
- Focused Alpha first reported a position in Corcept Therapeutics in Q1 2026 and held it in 1 quarter.
- Focused Alpha's Corcept Therapeutics position peaked at $1.31M in Q1 2026.
- 425 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Focused Alpha's 13F filing for Q2 2026, filed 7 Aug 2026.